Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: Observational study

British Medical Journal

Volumn 332, Issue 7539, 2006, Pages 452-454

  Chitty, Lyn S ^a   Kagan, Karl O ^b   Molina, Francisca S ^b   Waters, Jonathan J ^c   Nicolaides, Kypros H ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; FETUS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 21; X CHROMOSOME; Y CHROMOSOME;

ADOLESCENT; ADULT; ANEUPLOIDY; FEMALE; HUMANS; KARYOTYPING; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 33644777447     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38730.655197.AE     Document Type: Article

References (12)

1. Pertl B, Yau SC, Sherlock J, Davies AF, Mathew CG, Adinolfi M. Rapid molecular method for prenatal detection of Down's syndrome. Lancet 1994;343:1197-8.
2. Verma L, Macdonald F, Leedham P, McConachie M, Dhanjal S, Hulten M. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 1998;352:9-12.
3. Mann K, Fox SP, Abbs SJ, Yau SC, Scriven PN, Docherty Z, et al. Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis. Lancet 2001;358:1057-61.
4. Levett LJ, Liddle S, Meredith R. A large-scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy. Ultrasound Obstet Gynecol 2001;17:115-8.
5. Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, et al. International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. Hum Reprod 1999;14:1213-6.
6. Department of Health. Our inheritance, our future: realising the potential of genetics in the NHS. London: Stationery Office, 2003.
7. Adinolfi M, Sherlock J. Prenatal detection of chromosome disorders by QF-PCR. Lancet 2001;358:1030-1.
8. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998;351:343-6.
9. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;192:1005-21.
10. Grimshaw GM, Szczepura A, Hulten M, MacDonald F, Nevin NC, Sutton F, et al. Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 2003;7(10):1-146.
11. Leung WC, Lam YH, Wong Y, Lau ET, Tang MHY. The effect of fast reporting by amnio-PCR on anxiety levels in women with positive biochemical screening for Down syndrome-a randomized controlled trial. Prenat Diagn 2002;22:256-9.
12. Daniel A, Hook EB, Wulf G. Collaborative US data on prenatal diagnosis for parental carriers of chromosomal rearrangements: risks of unbalanced progeny. In: Daniel A, ed. The cytogenetics of mammalian autosomal rearrangements. New York: Alan R Liss, 1988:73-162.